anti-doping testing comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-04-27. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also marketed informally as Stenabolic |
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ |
| Molecular formula | C24H30ClN3O4S | Approximate molecular weight 492 g/mol |
| CAS Registry Number | 1379686-30-2 | Identifier for the parent compound |
| Regulatory status | Not approved for human use | Prohibited in sport by WADA |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
In business and investing, a megacap stock (also mega-cap or mega cap) is a stock whose market capitalization (market cap) is among the very largest. These are stocks of the largest publicly traded companies in the world. The market capitalization of a stock is the total value of the shares outstanding, calculated as (shares outstanding x share price). Stocks with large market caps, but smaller than megacaps, instead fall within the large-cap segment of the stock market. There is no official definition of, or full consensus agreement about, the exact market cap cutoff value for a stock to qualify as megacap, and it may vary internationally. However, for the 2020s US market, a minimum market cap value of $200 billion is often cited. Index providers, investment funds, and investment managers may have other definitions.
Cu2+ + 2 e− → Cu (cathode), E°cell = 0.34 V Copper sulfate is commonly included in teenage chemistry sets and undergraduate experiments. It is often used to grow crystals in schools and in Copper electroplating experiments despite its toxicity. Copper sulfate is often used to demonstrate an exothermic reaction, in which steel wool or magnesium ribbon is placed in an aqueous solution of CuSO4. It is used to demonstrate the principle of mineral hydration. The pentahydrate form, which is blue, is heated, turning the copper sulfate into the anhydrous form which is white, while the water that was present in the pentahydrate form evaporates. When water is then added to the anhydrous compound, it turns back into the pentahydrate form, regaining its blue color. Copper(II) sulfate pentahydrate can easily be produced by crystallization from solution as copper(II) sulfate, which is hygroscopic.
Aspartate kinase initiates the diaminopimelic acid pathway by phosphorylating aspartate and producing aspartyl phosphate. Aspartate semialdehyde dehydrogenase catalyzes the NADPH-dependent reduction of aspartyl phosphate to yield aspartate semialdehyde. 4-hydroxy-tetrahydrodipicolinate synthase adds a pyruvate group to the β-aspartyl-4-semialdehyde, and a water molecule is removed. This causes cyclization and gives rise to (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate. 4-hydroxy-tetrahydrodipicolinate reductase catalyzes the reduction of (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate by NADPH to yield Δ'-piperideine-2,6-dicarboxylate (2,3,4,5-tetrahydrodipicolinate) and H2O. Tetrahydrodipicolinate acyltransferase catalyzes the acetylation reaction that results in ring opening and yields N-acetyl α-amino-ε-ketopimelate. N-succinyl-α-amino-ε-ketopimelate-glutamate aminotransaminase catalyzes the transamination reaction that removes the keto group of N-acetyl α-amino-ε-ketopimelate and replaces it with an amino group to yield N-succinyl-L-diaminopimelate. N-acyldiaminopimelate deacylase catalyzes the deacylation of N-succinyl-L-diaminopimelate to yield L,L-diaminopimelate. DAP epimerase catalyzes the conversion of L,L-diaminopimelate to the meso form of L,L-diaminopimelate. DAP decarboxylase catalyzes the removal of the carboxyl group, yielding L-lysine.
=== Post-election activities === In November 2016, Sanders's book Our Revolution: A Future to Believe In was released; upon its release, it was number three on The New York Times Best Seller list. The audiobook later received a Grammy nomination for Best Spoken Word Album. In February 2017, he began webcasting The Bernie Sanders Show on Facebook live streaming. As of April 2, 2017, guests had included William Barber, Josh Fox, Jane Mayer, and Bill Nye. Polls taken in 2017 found him to be the most popular politician in the United States. In February 2018, Special Counsel Robert Mueller's investigation into Russian interference in the 2016 US elections concluded that Russians had communicated false information during the primary campaigns to help Sanders and Stein and harm Clinton. Sanders rejected the investigation's conclusion, saying that he had seen no evidence that Russians had helped his campaign. Furthermore, he questioned the Clinton campaign's lack of action to prevent Russian interference. He later said that his campaign had taken action to prevent Russian meddling in the election and that a campaign staffer had alerted the Clinton campaign. Politico noted that a Sanders campaign volunteer contacted a political action committee (PAC) that supported the Clinton campaign to report suspicious activities but that the Sanders campaign did not contact the Clinton campaign as such.
Sources: en.wikipedia.org
=== Next generation Mel's Drive-In === As of 2025, the next generation Mel's Drive-In chain has eight locations, four in San Francisco and four in the Los Angeles Area. Some Mel's Drive-In locations are not drive-ins but rather diners. For example, while founded in San Francisco, none of the locations in the city currently serve food to patrons' cars. The location near Downtown San Francisco, rechristened "Mel's Kitchen", has gone upscale, serving $12 cocktails, $16 burgers with locally sourced beef, ahi poke, acai smoothies, and avocado toast. That site was almost demolished in 2018 to build housing.
== Further reading == Rodrigues FB, Ferreira JJ (March 2017). "Opicapone for the treatment of Parkinson's disease" (PDF). Expert Opin Pharmacother. 18 (4): 445–453. doi:10.1080/14656566.2017.1294683. PMID 28234566. S2CID 5251815. Scott LJ (September 2016). "Opicapone: A Review in Parkinson's Disease". Drugs. 76 (13): 1293–1300. doi:10.1007/s40265-016-0623-y. PMID 27498199. S2CID 5787752.
John J. Abel Award Julius Axelrod Award Pharmacia-ASPET Award in Experimental Therapeutics Robert R. Ruffolo Career Achievement Award Travel Award for Pharmacology Educators Bernard B. Brodie Award in Drug Metabolism P.B. Dews Lifetime Achievement Award for Research in Behavioral Pharmacology Drug Metabolism Early Career Achievement Award Goodman and Gilman Award in Receptor Pharmacology Benedict R. Lucchesi Distinguished Lectureship in Cardiac Pharmacology Torald Sollmann Award in Pharmacology Paul M. Vanhoutte Distinguished Lectureship in Cardiovascular Pharmacology Travel awards to participate in its meetings are also given to students and postdocs. Chemotherapy Clinical pharmacology Drug metabolism Neuropharmacology Pharmacology Toxicology Official website Molecular Interventions magazine
Sources: en.wikipedia.org
Fermium was first discovered in the fallout from the 'Ivy Mike' nuclear test (1 November 1952), the first successful test of a hydrogen bomb. Initial examination of the debris from the explosion had shown the production of a new isotope of plutonium, 244Pu: this could only have formed by the absorption of six neutrons by a uranium-238 nucleus followed by two β− decays. At the time, the absorption of neutrons by a heavy nucleus was thought to be a rare process, but the identification of 244Pu raised the possibility that still more neutrons could have been absorbed by the uranium nuclei, leading to new elements. Element 99 (einsteinium) was quickly discovered on filter papers which had been flown through clouds from the explosion (the same sampling technique that had been used to discover 244Pu). It was then identified in December 1952 by Albert Ghiorso and co-workers at the University of California at Berkeley. They discovered the isotope 253Es (half-life 20.5 d) that was made by the capture of 15 neutrons by uranium-238 nuclei – which then underwent seven successive beta decays:
Hazard research is published: a study indicates common food allergies are not benign but are associated with increased risk of cardiovascular mortality (9 Nov), in a commentary, scientists warn that to "reduce plastic pollution efficiently and economically, policy should prioritize regulating and reducing upstream production rather than downstream pollution cleanup" as "popularized by The Ocean Cleanup" (9 Nov), social unconnectedness confirmed as likely substantial mortality risk factor using UK Biobank data (10 Nov), nanoplastic pollution and consumption identified as a likely Parkinson's disease risk factor (17 Nov), a review cautions "robust evidence has yet to emerge that [air treatment technologies] are effective at reducing respiratory or gastrointestinal infections in real world settings" (20 Nov), a content analysis of packaging marketing of infant and toddler foods in supermarkets suggests protection of young children's diets from harmful influence of food marketing is needed (28 Nov), a preprint suggests some large language models have an 'extractable memorization' flaw by which training data can be extracted at affordable costs by queries (28 Nov).
==== Diagnosis ==== A bone mineral density test, such as dual-energy X-ray absorptiometry, is commonly used to assess bone strength, particularly in the hip and spine. Screening is generally recommended for women aged 65 and older, postmenopausal women with risk factors, and some men based on clinical evaluation.
Nutrients used in cellular respiration include carbohydrates, amino acids and fatty acids. These nutrients are oxidized to produce carbon dioxide and water, and to release chemical energy to drive the organism's metabolism. Photosynthesis and cellular respiration are distinct processes, as they take place through different sequences of chemical reactions and in different cellular compartments (cellular respiration in mitochondria). The general equation for photosynthesis as first proposed by Cornelis van Niel is:
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.
No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.
The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.